Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Operating Leases (2019 - 2025)

Historic Operating Leases for Standard Biotools (LAB) over the last 7 years, with Q3 2025 value amounting to $22.0 million.

  • Standard Biotools' Operating Leases fell 2190.12% to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year decrease of 2190.12%. This contributed to the annual value of $25.6 million for FY2024, which is 1575.03% down from last year.
  • Latest data reveals that Standard Biotools reported Operating Leases of $22.0 million as of Q3 2025, which was down 2190.12% from $23.2 million recorded in Q2 2025.
  • Standard Biotools' Operating Leases' 5-year high stood at $42.0 million during Q2 2021, with a 5-year trough of $22.0 million in Q3 2025.
  • For the 5-year period, Standard Biotools' Operating Leases averaged around $33.2 million, with its median value being $32.2 million (2023).
  • As far as peak fluctuations go, Standard Biotools' Operating Leases skyrocketed by 1457.22% in 2021, and later plummeted by 2190.12% in 2025.
  • Standard Biotools' Operating Leases (Quarter) stood at $40.6 million in 2021, then fell by 16.06% to $34.1 million in 2022, then fell by 10.88% to $30.4 million in 2023, then fell by 15.75% to $25.6 million in 2024, then dropped by 14.12% to $22.0 million in 2025.
  • Its Operating Leases was $22.0 million in Q3 2025, compared to $23.2 million in Q2 2025 and $24.9 million in Q1 2025.